Learn More
Medchemexpress LLC Frovatriptan succinate hydrate | 158930-17-7 | 99.9% | 5 MG

Supplier: Medchemexpress LLC HYB1658A5MG
Frovatriptan succinate hydrate ((R)-Frovatriptan succinate hydrate) is a potent, high-affinity, selective, and orally active agonist for 5-HT1B (pK50 of 8.2) and 5-HT1D receptors. It demonstrates over 10-fold selectivity for 5-HT1B and 5-HT1D receptors compared to 5-HT1A, 5-HT1F, and 5-HT7, and more than 1000-fold selectivity over other 5-HT, dopamine, histamine H1, and α1-adrenoceptors. This compound has potential for use in migraine research.
- Potent, high-affinity, selective 5-HT1B and 5-HT1D receptor agonist.
- Orally active.
- Exhibits >10-fold selectivity for 5-HT1B and 5-HT1D over 5-HT1A, 5-HT1F, and 5-HT7.
- Potential for migraine research.
- Oral bioavailability of 22%-30%, not affected by food. Long terminal half-life of approximately 26 hours. Metabolized primarily by CYP1A2.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.